28
Participants
Start Date
February 29, 2012
Primary Completion Date
July 31, 2012
Study Completion Date
July 31, 2012
Ibuprofen
Liquid gelation capsules or tablets of 400 mg strength
Paracetamol
Paracetamol fast dissolving tablets of 500 mg strength
Placebo
Placebo tablets
Houston Institute for Clinical Research, Houston
Lead Sponsor
GlaxoSmithKline
INDUSTRY